Burning Rock Biotech Limited (NASDAQ: BNR)
$6.48
-0.7200 ( -10.00% ) 1.4K
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Market Data
Open
$6.48
Previous close
$7.20
Volume
1.4K
Market cap
$72.32M
Day range
$7.20 - $7.36
52 week range
$5.29 - $23.45
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Jun 03, 2024 |
6-k | Quarterly Reports | 3 | May 29, 2024 |
6-k | Quarterly Reports | 2 | May 14, 2024 |
20-f | Annual reports | 132 | Apr 29, 2024 |
6-k | Quarterly Reports | 2 | Apr 26, 2024 |
6-k | Quarterly Reports | 2 | Mar 28, 2024 |
6-k | Quarterly Reports | 2 | Jan 04, 2024 |
6-k | Quarterly Reports | 2 | Dec 20, 2023 |
6-k | Quarterly Reports | 2 | Nov 30, 2023 |
6-k | Quarterly Reports | 4 | Nov 22, 2023 |